Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
CBRE Group | CBRE | 21. nov 2024 | 131.65 | -0.10 |
CCC Intelligent Solutions | CCCS | 21. nov 2024 | 12.34 | +2.66 |
CCSC Technology International A | CCTG | 21. nov 2024 | 1.72 | -0.58 |
CDT Environmental Technology Investment Holdings | CDTG | 21. nov 2024 | 3.33 | +3.10 |
CDW | CDW | 21. nov 2024 | 178.17 | +1.24 |
CEA Industries | CEAD | 21. nov 2024 | 5.97 | -0.50 |
CECO Environmental | CECO | 21. nov 2024 | 30.20 | +0.77 |
Cedar Realty Trust B Pref | CDR-B | 21. nov 2024 | 15.59 | -4.09 |
Cedar Realty Trust C Pref | CDR-C | 21. nov 2024 | 14.10 | +2.10 |
CEF Income Composite Powershares | PCEF | 21. nov 2024 | 19.43 | +0.73 |
Cel-Sci | CVM | 21. nov 2024 | 0.60 | -3.74 |
Celanese | CE | 21. nov 2024 | 75.00 | +2.88 |
Celcuity | CELC | 21. nov 2024 | 12.73 | -0.39 |
Celestica | CLS | 21. nov 2024 | 91.44 | +5.13 |
Celldex Therapeutics | CLDX | 21. nov 2024 | 26.22 | -0.68 |
Cellebrite | CLBT | 21. nov 2024 | 20.18 | +6.21 |
Cellectar Biosciences | CLRB | 21. nov 2024 | 1.58 | +1.28 |
Cellectis ADR | CLLS | 21. nov 2024 | 1.86 | -2.62 |
Celsius | CELH | 21. nov 2024 | 29.05 | +4.84 |
Celularity A | CELU | 21. nov 2024 | 2.85 | -3.06 |
Cementos Pacasmayo ADR | CPAC | 21. nov 2024 | 5.93 | -9.33 |
CEMEX ADR | CX | 21. nov 2024 | 5.45 | +0.37 |
Cemtrex | CETX | 21. nov 2024 | 0.20 | -15.94 |
Cencora | COR | 21. nov 2024 | 245.69 | +1.02 |
Cenntro | CENN | 21. nov 2024 | 1.23 | -0.81 |
Cenovus Energy | CVE | 21. nov 2024 | 16.20 | +0.25 |
Centene | CNC | 21. nov 2024 | 60.35 | +2.12 |
CenterPoint Energy | CNP | 21. nov 2024 | 31.73 | +0.51 |
Centerra Gold | CGAU | 21. nov 2024 | 6.26 | +3.30 |
Centerspace | CSR-C | 21. nov 2024 | 24.98 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.